Impact Felt in Every Heartbeat Terumo Cardiovascular

TERUMO CARDIOVASCULAR

BY STEPHANIE SORENSON, MANAGER, MARKETING COMMUNICATIONS, TERUMO CARDIOVASCULAR

Terumo Cardiovascular saves lives through mission-driven innovations.

When a child is born, it is one of the happiest moments in a parent’s life. But for some, the unthinkable happens – the child is born with a congenital heart defect, and without urgent treatment the result will be fatal. Surgeons and teams of healthcare professionals work quickly to correct the problem, using their precision touch to mend a heart that is the mere size of a walnut. And alongside these skilled clinicians are the medical devices carefully engineered to serve as the patient’s heart and lungs, and continuously monitor the body’s vitals during surgery. Working together, clinicians and innovative technologies give patients the best possible care and a second chance at a bright future.

These are the life-saving technologies imagined and manufactured by Terumo Cardiovascular.

Terumo Cardiovascular is a global medical device manufacturer headquartered in Ann Arbor, Michigan. The company specializes in manufacturing and distributing medical devices for cardiac and vascular surgery with an emphasis on cardiopulmonary bypass, intra-operative monitoring, and vascular grafting.

Its products are used every day in a wide range of critical procedures affecting patients from babies that are only days-old to adults of all ages; procedures like pediatric congenital defect repairs, coronary artery bypass grafting and valve replacements, heart transplants and surgeries for peripheral artery disease. Today, heart teams in cardiac surgery centers around the world choose products made by Terumo Cardiovascular.

The driving force behind Terumo Cardiovascular technologies is its mission: Working together, we help save one more life, today and every day.

“If you were to ask any Associate about what motivates them in their work, you’ll almost always hear the same reply: Patients,” says President and CEO Robert DeRyke. “So many of us have been personally touched by the impact of cardiac surgery, whether through family, friends, and even through our own medical needs. We know just how much people rely on our products to receive life-saving care, and it inspires us to continually bring new solutions to the cardiovascular market.”

Terumo Cardiovascular shares a long and impactful history in healthcare as part of its parent company Terumo Corporation, which celebrated its 100 th Anniversary in 2021. Terumo Corporation began with the development of its first product, a clinical thermometer, in the 1920s. Since then, it has grown to become one of the largest medical device companies in the world, with more than 28,000 employees providing medical devices and services in more than 160 countries.

Perhaps now more than ever, Terumo Cardiovascular is harnessing its commitment to quality care to navigate the unprecedented challenges of the COVID pandemic.

“Terumo’s long-term view and contributions to healthcare have been incredibly important to our own business. We have 100 years of legacy and are preparing for the next 100 years, not just the next 1, 3, or 5,” says DeRyke. “We are in the business of saving lives, and our ability to serve both healthcare professionals and patients through our mission, vision and values is what distinguishes us in the market.”

Perhaps now more than ever, Terumo Cardiovascular is harnessing its commitment to quality care to navigate the unprecedented challenges of the COVID pandemic. As the needs of healthcare professionals and patients change, Terumo is pivoting to develop more dynamic and datacentric solutions.

“Even before COVID, we recognized that the needs of the market were shifting. A new generation of professionals is approaching the helm, professionals who expect data mobility, effortless user experience and communication integrations across care paths,” says DeRyke. “The pandemic has both reinforced and accelerated our investment in those kinds of innovations and we are excited to help define next-generation care that will save and improve more lives.”

While the company ramps up product development, it maintains its position as one of the leading clinical support resources for perfusion practices. Its team of certified clinical perfusionists serves customers around the globe, providing experiential training for new and seasoned perfusionists. Remote and on-demand educational training has become paramount in the COVID era, keeping healthcare professionals connected with the latest clinical best practices.

“While we are a medical device manufacturer, we choose to take a more comprehensive approach to serving our customers,” says DeRyke. “Sharing knowledge, exploring unique situations and cases, and demonstrating the latest techniques can elevate healthcare professionals’ skills and ability to optimize patient outcomes.”

Whether through its innovative technologies or educational programs, Terumo Cardiovascular will continually strive to deliver meaningful impact to help save one more life, today and every day.

WWW.TERUMOCV.COM